Publicaciones (58) Publicaciones de MARCO CORDANI

2024

  1. Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression

    Cancers, Vol. 16, Núm. 4

  2. Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression

    Cancers, Vol. 16, Núm. 4, pp. 807

  3. Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle

    Cancer Letters, Vol. 585

  4. Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype

    Frontiers in Cellular and Infection Microbiology, Vol. 14

  5. Metal-based nanoparticles in cancer therapy: Exploring photodynamic therapy and its interplay with regulated cell death pathways

    International Journal of Pharmaceutics, Vol. 649

  6. Metastatic outgrowth via the two-way interplay of autophagy and metabolism

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 3

  7. The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives

    Seminars in Cancer Biology, Vol. 99, pp. 24-44

  8. Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

    Cell Communication and Signaling, Vol. 22, Núm. 1

2023

  1. A comparison study between doxorubicin and curcumin co-administration and co-loading in a smart niosomal formulation for MCF-7 breast cancer therapy

    European Journal of Pharmaceutical Sciences, Vol. 191, pp. 106600

  2. A comprehensive review on novel targeted therapy methods and nanotechnology-based gene delivery systems in melanoma

    European Journal of Pharmaceutical Sciences, Vol. 187, pp. 106476

  3. Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery

    European Journal of Pharmacology, Vol. 958

  4. Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective (Cell & Bioscience, (2023), 13, 1, (44), 10.1186/s13578-023-00986-9)

    Cell and Bioscience

  5. Editorial: Autophagy modulation in cancer treatment utilizing nanomaterials and nanocarriers

    Frontiers in Oncology

  6. Metal-based Nanoparticles in Cancer Therapy: Exploring Photodynamic Therapy and its Interplay with Regulated Cell Death Pathways (Pre-Proof)

    International Journal of Pharmaceutics, pp. 123622

  7. Metastatic outgrowth via the two-way interplay of autophagy and metabolism (In Press, Corrected Proof)

    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, pp. 166824

  8. Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective

    Cell and Bioscience, Vol. 13, Núm. 1

  9. Preparation and characterization of full-spectrum cannabis extract loaded poly(thioether-ester) nanoparticles: In vitro evaluation of their antitumoral efficacy

    Colloids and Surfaces A: Physicochemical and Engineering Aspects, Vol. 658

  10. Retinoblastoma: present scenario and future challenges

    Cell Communication and Signaling, Vol. 21, Núm. 1

2022

  1. Clinical Trials Involving Chemotherapy-Based Nanocarriers in Cancer Therapy: State of the Art and Future Directions

    Cancer Nanotechnology (Springer), pp. 325-383

  2. Corrigendum to ‘Non-ionic surfactant vesicles as novel delivery systems for sulfasalazine: Evaluation of the physicochemical and cytotoxic properties’ [Journal of Molecular Structure 1230 (2021) 129874] (Journal of Molecular Structure (2021) 1230, (S0022286021000053), (10.1016/j.molstruc.2021.129874))

    Journal of Molecular Structure